Cargando…
The Bonebridge BCI 602 Active Transcutaneous Bone Conduction Implant in Children: Objective and Subjective Benefits
Background: the Bonebridge hearing implant is an active transcutaneous bone conduction implant suitable for various types of hearing loss. It was first launched in 2012 as the BCI 601, with a newer internal part (BCI 602) released in 2019. With the new size and shape, the BCI 602 can be used in pati...
Autores principales: | Cywka, Katarzyna B., Skarżyński, Henryk, Król, Bartłomiej, Skarżyński, Piotr H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707547/ https://www.ncbi.nlm.nih.gov/pubmed/34945210 http://dx.doi.org/10.3390/jcm10245916 |
Ejemplares similares
-
Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes
por: Cywka, Katarzyna B., et al.
Publicado: (2022) -
Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results
por: Król, Bartłomiej, et al.
Publicado: (2021) -
Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report
por: Król, Bartłomiej, et al.
Publicado: (2020) -
Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant
por: Sprinzl, Georg, et al.
Publicado: (2023) -
Self-Rated Benefits of Auditory Performance after Bonebridge Implantation in Patients with Conductive or Mixed Hearing Loss, or Single-Sided Deafness
por: Ratuszniak, Anna, et al.
Publicado: (2022)